Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Clinical trial NCT06373081 · UNKNOWN

Trial details

NCT number: NCT06373081
Sponsor: Shanghai Changzheng Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Sjogren's Syndrome Systemic Sclerosis Inflammatory Myopathy ANCA Associated Vasculitis Antiphospholipid Syndrome

Start date: 2024-04-20
Primary completion: 2025-04-15
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.